Vietnamese Patent Granted for RECCE Anti-Infectives
Filed with ASX · · 3 pages · English
Summary by 6ix AI
Recce Pharmaceuticals Ltd. has announced the granting of a patent in Vietnam for its RECCE anti-infectives, which is a significant milestone for the company. This patent adds to Recce's intellectual property portfolio, which already includes patents in major pharmaceutical markets worldwide. The CEO emphasized that this expansion supports their strategy to combat antibiotic resistance globally.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Recce Pharmaceuticals Ltd. on 6ix
Story so far
Earlier from Recce Pharmaceuticals
- AUD $3.7M Income Tax Refund Received
- Placement & SPP to raise $8 million
- HREC Approval Accelerates Global Phase 3 DFI Strategy
- Addendum to Recce Signs Middle East Licensing Term Sheet
- Recce Signs Middle East Licensing Term Sheet
Later from Recce Pharmaceuticals
- U.S. Government Releases US$66.9B AMR Biodefense Strategy
- Notice of General Meeting/Proxy Form
- Application for quotation of securities - RCE
- Completion of Share Purchase Plan and Shortfall Notice
- Cleansing Notice
Follow Recce Pharmaceuticals into a list and get an email when it puts out news.
Follow Recce Pharmaceuticals